Packaged bakery food company Flowers Foods (NYSE: FLO) missed Wall Street’s revenue expectations in Q2 CY2026, with sales falling 4% year on year to $1.19 billion. The company’s full-year revenue guidance of $5.11 billion at the midpoint came in 1.2% below analysts’ estimates. Its non-GAAP profit of $0.21 per share was 5.8% below analysts’ consensus estimates.

Is now the time to buy FLO? Find out in our full research report (it’s free for active Edge members).

StockStory’s Take

Flowers Foods reported second quarter results below Wall Street’s expectations, with management citing persistent pressure in the fresh packaged bread category. CEO Ryals McMullian highlighted that household budget constraints, evolving consumer preferences, and increased competition weighed on volumes. Management described the quarter as “challenging” and acknowledged that their innovation pipeline lagged recent shifts in demand, particularly for smaller formats and specialty breads. McMullian emphasized that, despite these setbacks, the company is accelerating efforts to address gaps in its portfolio and adapt more quickly to changing market dynamics.

Looking ahead, management’s updated guidance factors in new business wins, cost savings, and a ramp-up of product innovation to stabilize performance. McMullian pointed to upcoming launches in protein breads, half loaves, and sourdough, as well as ongoing investments behind core brands like Nature’s Own. CFO Diego Scaglione cautioned that inflationary pressures, particularly in commodities and fuel, remain a concern for 2027, but said productivity initiatives and price pack architecture are expected to help offset some of these headwinds. Management views the current strategy as necessary to restore growth and margin stability.

Key Insights from Management’s Remarks

Management attributed Q2’s underperformance primarily to volume declines, driven by consumer trade-down to lower-priced or private label bread, as well as gaps in Flowers Foods’ product offerings.

• Category shifts hurt volumes: Shifting consumer preferences toward smaller loaves, sourdough, and protein-rich breads led to underperformance in core segments, with management admitting their innovation pipeline lagged behind these trends.
• Private label competition intensified: The company saw increased consumer trade-down to private label and value brands, particularly as household budgets remained pressured by inflation. This dynamic was cited as a significant driver of lost share.
• Nature’s Own relaunch underway: Management began a major relaunch of its flagship Nature’s Own brand, noting positive early feedback but cautioning that results will take time to materialize. Investments in marketing and product improvements are expected to support brand recovery.
• Cost savings and productivity measures: Flowers Foods implemented additional cost reduction initiatives and cited roughly $200 million in cumulative savings over recent years. These measures are expected to provide a tailwind as the company exits 2026 and enters 2027.
• Innovation focus for recovery: The company is accelerating the rollout of new products in underpenetrated categories, including half loaves and expanded sourdough offerings, to better meet evolving consumer demand. Management believes this strategy, alongside new business wins, will support a gradual recovery in both retail and away-from-home channels.

Drivers of Future Performance

Management’s outlook centers on stabilizing volumes and margins through new product launches, cost controls, and addressing portfolio gaps, while navigating ongoing inflation and competitive pressures.

• Innovation pipeline expansion: Management expects new products, particularly in smaller formats, sourdough, and protein breads, to better align with shifting consumer preferences. These launches are anticipated to drive incremental volume and improve overall portfolio mix in the coming quarters.
• Cost discipline and productivity: Ongoing productivity initiatives and cost reduction efforts, including network optimization and restructuring, are expected to help offset inflationary headwinds. Management highlighted a $20 million cost tailwind for 2027, but cautioned that fixed-cost leverage may remain challenging if volumes do not recover.
• Competitive pricing and promotional activity: The company is re-evaluating its pricing and promotional strategies in response to heightened competition and increased promotional intensity in the category. Management signaled that while price is a factor, addressing gaps in the portfolio and meeting consumer needs will be more critical for regaining share.

Catalysts in Upcoming Quarters

In the coming quarters, our analysts will be closely watching (1) the market response and sales impact of new product launches in categories like sourdough and half loaves, (2) evidence of stabilization or improvement in volumes for both retail and away-from-home channels, and (3) the effectiveness of cost-saving and productivity initiatives in supporting margins. Additionally, the ongoing Nature’s Own relaunch and shifts in competitive pricing strategies will be important to track for signs of business recovery.

Flowers Foods currently trades at $7.16, in line with $7.09 just before the earnings. Is the company at an inflection point that warrants a buy or sell? Find out in our full research report (it’s free).

Stocks That Trumped Tariffs

ONE MORE THING: Top 5 Growth Stocks. The biggest stock winners almost always had one thing in common before they ran. Revenue growing like crazy. Meta. CrowdStrike. Broadcom. Our AI flagged all three. They returned 315%, 314%, and 455%, respectively.

Find out which 5 stocks it’s flagging this month — FREE. Get Our Top 5 Growth Stocks for Free HERE.

Stocks that have made our list include now familiar names such as Nvidia (+1,460% between June 2020 and June 2025) as well as under-the-radar businesses like the once-small-cap company Comfort Systems (+1,154% between June 2020 and June 2025). Find your next big winner with StockStory today.